BioSpace News Archive

axialHealthcare, a care optimization company navigating substance use issues for patients, providers, and health plans, today announced it has closed $15 million in equity financing to accelerate its expansion into the substance use disorder (SUD) treatment and recovery sector, led by previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund.

DNA Script today announced the presentation of new data in support of the company’s innovative enzymatic DNA synthesis (EDS) technology

Healthcare IT changemakers will gather in Orlando March 9-13 for HIMSS20, where they’ll find a wealth of knowledge and resources for health information technology needs, all in one place.

Ubiquitin Conjugating Enzyme serves as key target to BERG’s oncology therapeutics discovery efforts

Worldwide Rescue & Security, Inc. provides advice to lessen exposure to the virus.

Sorrento Therapeutics, Inc. announced that an interim analysis of an ongoing Phase 1b study of resiniferatoxin administered via epidural route in patients with intractable cancer pain has generated positive data.

Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response.

Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and financial results for the full year 2019.

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31, 2019.

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, reported financial results for the quarter and year ended December 31, 2019.